Effect of teriparatide on bone mineral density and biochemical markers in Japanese women with postmenopausal osteoporosis: A 6-month dose-response study

Journal of Bone and Mineral Metabolism

Volumn 26, Issue 6, 2008, Pages 624-634

  Miyauchi, Akimitsu ^a   Matsumoto, Toshio ^b   Shigeta, Hirofumi ^a   Tsujimoto, Mika ^a   Thiebaud, Daniel ^a   Nakamura, Toshitaka ^c  

^a ELI LILLY AND COMPANY   (United States)

^b UNIVERSITY OF TOKUSHIMA   (Japan)

^c UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

Author keywords

Bone mineral density; Bone turnover marker; Osteoporosis; Parathyroid hormone; Teriparatide

Indexed keywords

ALKALINE PHOSPHATASE; BIOCHEMICAL MARKER; CARBOXY TERMINAL TELOPEPTIDE; PARATHYROID HORMONE[1-34]; PLACEBO; PROCOLLAGEN C PROTEINASE; BIOLOGICAL MARKER; BONE DENSITY CONSERVATION AGENT;

ADULT; ARTICLE; BONE DENSITY; BONE TURNOVER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFECT; DRUG SAFETY; FEMALE; FEMUR NECK; FRAGILITY FRACTURE; HUMAN; JAPANESE; LUMBAR SPINE; MAJOR CLINICAL STUDY; MULTICENTER STUDY; OSSIFICATION; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; AGED; BLOOD; FEMUR; HIP; JAPAN; LUMBAR VERTEBRA; PATHOPHYSIOLOGY; RADIOGRAPHY;

AGED; BIOLOGICAL MARKERS; BONE DENSITY; BONE DENSITY CONSERVATION AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FEMUR; HIP; HUMANS; JAPAN; LUMBAR VERTEBRAE; OSTEOPOROSIS, POSTMENOPAUSAL; PLACEBOS; TERIPARATIDE;

EID: 58149218823     PISSN: 09148779     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00774-008-0871-3     Document Type: Article

References (30)

1. J.A. Kanis J.E. Brazier M. Stevenson N.W. Calvert M. Lloyd Jones 2002 Treatment of established osteoporosis: a systematic review and cost-utility analysis Health Technol Assess 6 29 1 146
2. R.M. Neer C.D. Arnaud J.R. Zanchetta R. Prince G.A. Gaich J.Y. Reginster A.B. Hodsman E.F. Eriksen S. Ish-Shalom H.K. Genant O. Wang B.H. Mitlak 2001 Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis N Engl J Med 344 19 1434 1441
3. M.R. McClung J. San Martin P.D. Miller R. Civitelli F. Bandeira M. Omizo D.W. Donley G.P. Dalsky E.F. Eriksen 2005 Opposite bone remodeling effects of teriparatide and alendronate in increasing bone mass Arch Intern Med 165 15 1762 1768
4. T.M. Keaveny D.W. Donley P.F. Hoffmann B.H. Mitlak E.V. Glass J.A. San Martin 2007 Effects of teriparatide and alendronate on vertebral strength as assessed by finite element modeling of QCT scans in women with osteoporosis J Bone Miner Res 22 1 149 157
5. Y. Jiang J.J. Zhao B.H. Mitlak O. Wang H.K. Genant E.F. Eriksen 2003 Recombinant human parathyroid hormone (1-34) [teriparatide] improves both cortical and cancellous bone structure J Bone Miner Res 18 11 1932 1941
6. C.L. Benhamou 2007 Effects of osteoporosis medications on bone quality Joint Bone Spine 74 1 39 47
7. Miki T, Naka H (1996) Tests for calcium metabolism. In: Morii H (ed) Handbook for Bone/Calcium Test (in Japanese). Nakayama-Shoten, Tokyo, pp 10-14
8. J.A. Kanis F. Borgstrom C. De Laet H. Johansson O. Johnell B. Jonsson A. Oden N. Zethraeus B. Pfleger N. Khaltaev 2005 Assessment of fracture risk Osteoporos Int 16 6 581 589
9. J.A. Kanis A. Oden O. Johnell H. Johansson C. De Laet 2007 The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women Osteoporos Int 18 8 1033 1046
10. J.Y. Reginster N. Sarlet 2006 The treatment of severe postmenopausal osteoporosis: a review of current and emerging therapeutic options Treat Endocrinol 5 1 15 23
11. H. Hagino 2007 Features of limb fractures: a review of epidemiology from a Japanese perspective J Bone Miner Metab 25 5 261 265
12. A. Sakai T. Sakata S. Ikeda S. Uchida R. Okazaki T. Norimura M. Hori T. Nakamura 1999 Intermittent administration of human parathyroid hormone (1-34) prevents immobilization-related bone loss by regulating bone marrow capacity for bone cells in ddY mice J Bone Miner Res 14 10 1691 1699
13. T. Bellido A.A. Ali L.I. Plotkin Q. Fu I. Gubrij P.K. Roberson R.S. Weinstein C.A. O'Brien S.C. Manolagas R.L. Jilka 2003 Proteasomal degradation of Runx2 shortens parathyroid hormone-induced anti-apoptotic signaling in osteoblasts. A putative explanation for why intermittent administration is needed for bone anabolism J Biol Chem 278 50 50259 50272
14. A.B. Hodsman B.M. Steer 1993 Early histomorphometric changes in response to parathyroid hormone therapy in osteoporosis: evidence for de novo bone formation on quiescent cancellous surfaces Bone (NY) 14 3 523 527
15. Y.L. Ma Q. Zeng D.W. Donley L.G. Ste-Marie J.C. Gallagher G.P. Dalsky R. Marcus E.F. Eriksen 2006 Teriparatide increases bone formation in modeling and remodeling osteons and enhances IGFII immunoreactivity in postmenopausal women with osteoporosis J Bone Miner Res 21 6 855 864
16. R. Lindsay F. Cosman H. Zhou M.P. Bostrom V.W. Shen J.D. Cruz J.W. Nieves D.W. Dempster 2006 A novel tetracycline labeling schedule for longitudinal evaluation of the short-term effects of anabolic therapy with a single iliac crest bone biopsy: early actions of teriparatide J Bone Miner Res 21 3 366 373
17. J.E. Compston 2007 Skeletal actions of intermittent parathyroid hormone: effects on bone remodelling and structure Bone (NY) 40 6 1447 1452
18. T. Fujita T. Inoue H. Morii R. Morita H. Norimatsu H. Orimo H.E. Takahashi K. Yamamoto M. Fukunaga 1999 Effect of an intermittent weekly dose of human parathyroid hormone (1-34) on osteoporosis: a randomized double-masked prospective study using three dose levels Osteoporos Int 9 4 296 306
19. T. Matsumoto M. Shiraki H. Hagino H. Iinuma T. Nakamura 2006 Daily nasal spray of hPTH (1-34) for 3 months increases bone mass in osteoporotic subjects: a pilot study Osteoporos Int 17 10 1532 1538
20. P. Chen P.D. Miller P.D. Delmas D.A. Misurski J.H. Krege 2006 Change in lumbar spine BMD and vertebral fracture risk reduction in teriparatide-treated postmenopausal women with osteoporosis J Bone Miner Res 21 11 1785 1790
21. P. Chen P.D. Miller R. Recker H. Resch A. Rana I. Pavo A.A. Sipos 2007 Increases in BMD correlate with improvements in bone microarchitecture with teriparatide treatment in postmenopausal women with osteoporosis J Bone Miner Res 22 8 1173 1180
22. R. Marcus O. Wang J. Satterwhite B. Mitlak 2003 The skeletal response to teriparatide is largely independent of age, initial bone mineral density, and prevalent vertebral fractures in postmenopausal women with osteoporosis J Bone Miner Res 18 1 18 23
23. A.W. Kung E.G. Pasion M. Sofiyan E.M. Lau B.K. Tay K.S. Lam K. Wilawan B. Ongphiphadhanakul D. Thiebaud 2006 A comparison of teriparatide and calcitonin therapy in postmenopausal Asian women with osteoporosis: a 6-month study Curr Med Res Opin 22 5 929 937
24. J.S. Hwang S.T. Tu T.S. Yang J.F. Chen C.J. Wang K.S. Tsai 2006 Teriparatide vs. calcitonin in the treatment of Asian postmenopausal women with established osteoporosis Osteoporos Int 17 3 373 378
25. P. Chen J.H. Satterwhite A.A. Licata E.M. Lewiecki A.A. Sipos D.M. Misurski R.B. Wagman 2005 Early changes in biochemical markers of bone formation predict BMD response to teriparatide in postmenopausal women with osteoporosis J Bone Miner Res 20 6 962 970
26. H. Dobnig A. Sipos Y. Jiang A. Fahrleitner-Pammer L.G. Ste-Marie J.C. Gallagher I. Pavo J. Wang E.F. Eriksen 2005 Early changes in biochemical markers of bone formation correlate with improvements in bone structure during teriparatide therapy J Clin Endocrinol Metab 90 7 3970 3977
27. R. Eastell J.H. Krege P. Chen E.V. Glass J.Y. Reginster 2006 Development of an algorithm for using PINP to monitor treatment of patients with teriparatide Curr Med Res Opin 22 1 61 66
28. M.R. Rubin J.P. Bilezikian 2003 The anabolic effects of parathyroid hormone therapy Clin Geriatr Med 19 2 415 432
29. E. Canalis A. Giustina J.P. Bilezikian 2007 Mechanisms of anabolic therapies for osteoporosis N Engl J Med 357 9 905 916
30. J.R. Zanchetta C.E. Bogado J.L. Ferretti O. Wang M.G. Wilson M. Sato G.A. Gaich G.P. Dalsky S.L. Myers 2003 Effects of teriparatide [recombinant human parathyroid hormone (1-34)] on cortical bone in postmenopausal women with osteoporosis J Bone Miner Res 18 3 539 543